BITS Pilani

  • Page last updated on Wednesday, October 04, 2023

Seminars

banner
Seminars

Seminars

 

Seminars/Workshops/Conferences/Symposia attended 

 

1.     I have attended 8th PAGIN workshop on "Data analysis using NONMEM" organized by PAGIN and ACTREC, Mumbai held between 1st - 3rd  August 2016 at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC, TMC), Mumbai, India.

2.   I have attended a seminar on “Insights into Process Variables - A Step Towards Quality by Design” organized by ACG Worldwide in collaboration with Indian Pharmaceutical Association (IPA), Telangana State Branch held between 2nd - 3rd February 2017 held at Hotel Radisson Blu Plaza, Hyderabad, India.

3.     I have attended an International Conference titled “Novel Formulation Strategies” conducted by Select Biosciences India Private Limited, during April 20th-22nd held at Hitech City, Hyderabad, India.

4.     I have attended a training course on “A Practical Approach to Effective Design of Experiments (DOE) in Pharma Development” conducted by Select Biosciences India Private Limited, held on 19th April at Hitech City, Hyderabad, India.

5.      Srividya M, Joseph S, Ravi PR. “Effect of pharmaceutical excipients on intestinal permeability of ester prodrug tenofovir dioproxil fumurate”. Presented at 66th Indian Pharmaceutical Congress, during Jan 23rd -25th, 2015, at Hyderabad, India.

6.  Presented a paper titled “Design of Polymeric Nanocapsules for Raloxifene hydrochloride by Multiple Emulsion Method (w/o/w) using Rotatable Central Composite Design Model” 2nd International Conference and Exhibition on Pharma Regulatory Affairs, during Nov 23-24, 2012, at Hyderabad, India.

7.  Participated in a hands-on workshop on “Introduction to Phoenix WinNonlin”, conducted by Pharsight, USA, during Nov 1-3, 2012, at Hyderabad, India. 


List of Poster Presentations in National/International Symposiums

 

1.  Joseph S, Dalvi A V, Rajith K R Rajoli, Ravi P R “Chitosan nanoparticles for oral delivery of tenofovir disoproxil fumarate: design and optimization, in vivo evaluation, and PBPK modelling in humans’ presented at 16th International Symposium On 'Advances in Technology and Business Potential on New Drug Delivery Systems' held on Friday, 23rd and 24th  February, 2018 at Mumbai, India.

2.  Ravi P R, Aditya N. “Role of soy lecithin–chitosan hybrid nanoparticles in improving the oral bioavailability of raloxifene” at the “International Conference on Challenges in Drug Discovery and Delivery (ICCD3 - 2017)” held during 2nd – 4th March, 2017 at BITS Pilani (Pilani Campus), Pilani, Rajasthan (India). (Awarded Best Oral Presentation – First Prize)

3.    Joseph S, Reddy M, Odapalli K P, Ravi P R. “Oral pharmacokinetic interaction of ester rich fruit juices and pharmaceutical excipients with tenofovir disoproxil fumarate in male Wistar rats” at the “International Conference on Challenges in Drug Discovery and Delivery (ICCD3 - 2017)” held during 2nd – 4th March, 2017 at BITS Pilani (Pilani Campus), Pilani, Rajasthan,India.

4.    Avantika D, Shailender J, Asmitha V, Ravi P R; ‘Formulation Development, In Vitro Evaluation, And In Vivo Pharmacokinetic Studies Of A Self Emulsifying Drug Delivery System For Amlodipine Besylate’ at the “International Conference on Challenges in Drug Discovery and Delivery (ICCD3 - 2017)” held during 2nd – 4th March, 2017 at BITS Pilani (Pilani Campus), Pilani, Rajasthan, India

5.   Joseph S, Saha P, Dalvi A, Myneni S,Ravi P R. “Tenofovir disoproxil fumarate loaded PLGA nanoparticles for enhanced oral absorption: Effect of experimental variables and in vitro, in vivo and ex vivo evaluation” at PEAR on 17th and 18th March 2017, held at JNTU, Hyderabad, India

6.     Aditya N, Kathuria H, Vats R. and Ravi P R. Conference Proceeding: “Solid lipid nanoparticles for oral delivery of raloxifene: Optimization, PK, bio-distribution and uptake studies”. at 13th International Symposium of CRS-Indian Chapter, in Jan 2013, held at Mumbai, India

7.    Aditya N, R. Vats R and Ravi P R. Conference Proceeding: “Self-assembled Chitosan-Soyalecithin nanocomplexes for oral delivery of raloxifene”. 3rd NanoToday 2013 Conference, in Dec 2013, held at Biopolis, Singapore.

8.  Vats R, Aditya N and Ravi P R. Conference Proceeding: “Development and optimization of polycaprolactone nanoparticles for oral delivery of lopinavir using Box-Behnken statistical design”. At 13th International Symposium of CRS-Indian Chapter, in Jan 2013, held at Mumbai, India.

9.      Vats R, N Aditya N and Ravi P R. Conference Proceeding: Polymeric nanoparticles of lopinavir to improve its oral bioavailability. 39th Annual Meeting and Exposition of the Controlled Release Society, during 15th -18th July,2012 at Quebec City, Canada 

10.  Aditya N, Vats R, Ravi P R. Conference proceedings “Lipid nanoparticles for oral delivery of raloxifene hydrochloride: Preparation, characterization, bio-distribution and pharmacokinetic studies” at AAPS Annual Meeting and Exposition, during 14th -18th Oct, 2012, at McCormick Place, Chicago USA.

11.  Aditya N, Kathuria H, Malekar S and Ravi P R. Solid lipid nanoparticles and nanostructured lipid carriers for oral delivery of raloxifene hydrochloride” at J-Talent: A national level technical symposium, on 30th Mar 2012, held at Hyderabad, India.

12. Ravi P R, Kotreka U K, Saha R N. “Design and evaluation of oral controlled release tablet formulations of lamivudine prepared using ethyl cellulose and carbopol-971P; at AAPS Annual Meeting and Exposition, 11th – 15th Nov 2007, held at San Diego, USA.

13. Ravi P R, Kotreka U K, Saha R N. “Design and evaluation of oral controlled release tablet formulations of zidovudine prepared using ethyl cellulose and carbopol-971P at AAPS Annual Meeting and Exposition, during 29th Oct – 2nd Nov 2006, held at San Antonio, Texas, USA.

14.  Ravi P R, Sindhura G., Ranendra N. Saha Design and evaluation of oral controlled release tablet formulations of lamivudine; at AAPS Annual Meeting and Exposition, during 6th -10th Nov 2005, held at Nashville, Tennessee, USA.

15. Ravi P R, Mishra A, Saha R N; “Design of oral controlled release formulations of zidovudine using hydroxypropylmethylcellulose-based tablets”; at AAPS Annual Meeting and Exposition, during 7th -11th Nov 2004, held at Baltimore, USA.

16. Ravi P R, Saha R N; “A new rapid, simple and validated UV spectrophotometric method for estimation of zidovudine in bulk, formulations and dissolution samples”; at AAPS Annual Meeting and Exposition, during 7th -11th Nov 2004, held at Baltimore, USA.

17. Ravi P R, Chandran S. “Application of optimization technique in the design of oral controlled release formulations of celecoxib”; at National Conference on Mathematical Modelling & Analysis, during 8th - 9th Oct 2004, at BITS, Pilani, India.

18. Saha R N, Chandran S, Pravin R. J, Ravi P R, Archna R. “Determination of celecoxib, flurbiprofen and nimesulide in pharmaceutical dosage form by liquid chromatography”; at 27th  Symposium on high performance liquid phase separations and related techniques, during 15th -19th  June 2003, held at Nice, France.

19.  Chandran S, Ravi P R, Archna R.,Saha R N. “Validated reverse phase liquid chromatographic method for the estimation of some NASIDs- celecoxib, flurbiprofen and nimesulide in human serum; at  27th  Symposium on high performance liquid phase separations and related techniques, during15th -19th  June 2003, held at Nice, France.

20. Ravi P R, Sandeep P., Chandran S, Saha R N. “Oral controlled delivery of celecoxib- design, evaluation and optimization”; at International symposium on emerging trends in genomics and proteomics, education and research, during 12th -13th Jan, 2003, held at BITS-Pilani, Pilani, Rajasthan, India.

21. Chandran S, Ravi P R, Sudha R., Pravin P. R., Saha R N; “Determination of nimesulide in human serum by liquid chromatography”; at 54th Indian Pharmaceutical Congress, during 13th -15th Dec. 2002, held at Pune, India.

22. Chandran S, Ravi P R, Sandeep P.,Saha R N. “Application of optimization technique in the design of oral controlled release formulations of celecoxib”; at  54th Indian Pharmaceutical Congress, during 13th -15th  Dec., 2002, held at Pune, India.

23. Validated reverse phase liquid chromatographic method for the estimation of flurbiprofen in serum and aqueous humor. Sajeev Chandran, Punna Rao Ravi, Archna R., Induja V., Ranendra N. Saha; 54th Indian Pharmaceutical Congress, 13-15 Dec., 2002, Pune, India.

24. Saha R N, Chandran S, Girish B., Ravi P R. “Studies on design and evaluation of controlled release polymeric discs for ocular delivery of flurbiprofen and celecoxib”; at 4th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems, Organized by Controlled Release Society Inc. USA, Indian Chapter, during 22nd -23rd Feb. 2002, held at Mumbai, India.

25.   Ravi P R, Chandran S, Saha R N. “Studies on development of controlled release oral formulation of celecoxib”; at 53rd Indian Pharmaceutical Congress, during 21st -23rd Dec., 2001, held at New Delhi, India. 

Quick Links

    An Institution Deemed to be University estd. vide Sec.3 of the UGC Act,1956 under notification # F.12-23/63.U-2 of Jun 18,1964

    © 2024 Centre for Software Development,SDET Unit, BITS-Pilani, India.

    Designed and developed by fractal | ink design studios